Assessment of Stent Malapposition and Neointimal Coverage on Optical coHerence Tomography at Post-procedure and 3 Months After Platinum Chromium Alloy Of the Element™ Stent Implantation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01581515

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01581515
Other papers using this trial's data
  • Randomized comparison of acute stent malapposition between platinum-chromium versus cobalt-chromium everolimus-eluting stents The international journal of cardiovascular imaging, 2015-02 DOI, PubMed 25345751

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01581515. Randomized; single masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2014-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assessment of Stent Malapposition and Neointimal Coverage on Optical coHerence Tomography at Post-procedure and 3 Months After Platinum Chromium Alloy Of the Element™ Stent Implantation
Acronym
ANCHOR
Intervention (Device)
Promus Element everolimus eluting coronary stent
Intervention (Device)
Xience Prime everolimus eluting coronary stent
Lead sponsor
Yonsei University (class: other)

Record details

Record id
cardio:ct-nct01581515
Content hash
5d8cfaa1117442f6420fe38ee9fbc5d9372adeedcf657892cda3868923d42fcb